ANKRD18A Knockout HeLa Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal cell population derived from HeLa cells, with specific disruption of the ANKRD18A gene. This format yields a diverse pool of cells carrying loss-of-function mutations, providing a robust model that avoids clonal artifacts. The polyclonal nature ensures that the knockout phenotype reflects the average effect across a heterogeneous population, facilitating reliable gene function analysis. Researchers can use these cells for downstream applications after standard culture recovery.
The HeLa host cell line is a human cervical epithelial adenocarcinoma cell line positive for HPV18, widely used in cancer research for its well-characterized biology and experimental tractability. Its epithelial origin and transformed phenotype make it a relevant background for studying oncogenic processes and transcriptional regulation.
ANKRD18A encodes a protein with multiple ankyrin repeat domains, which are known to mediate protein?Cprotein interactions. The protein is predicted to function as a scaffold, potentially assembling transcriptional co-regulatory complexes to modulate gene expression. Although its direct interacting partners and regulatory mechanisms remain uncharacterized, it is thought to participate in transcriptional regulatory networks. This knockout model thus provides a tool to explore its possible functions in gene regulation.
Disruption of ANKRD18A in HeLa cells creates a loss-of-function system to investigate its role in cancer-associated phenotypes. Given its putative transcriptional scaffolding activity, knockout may lead to changes in proliferation, migration, or cell cycle progression. This model is significant for studying ANKRD18A in cervical adenocarcinoma, and for identifying novel protein interaction networks and regulatory mechanisms in epithelial cancer cells. It also enables exploratory studies into the potential role of ANKRD18A as a tumor suppressor or oncogene, depending on the cellular context.
Applications include knockout validation by Western blotting, RT-qPCR, and Sanger sequencing, followed by functional assays such as proliferation (MTT or CellTiter-Glo), wound healing migration, and flow cytometry for cell cycle analysis. The cells are also suitable for co-immunoprecipitation to identify interacting factors, as well as for drug target identification screens in a cancer-relevant background. This polyclonal knockout cell population provides a versatile platform for advanced biomedical research. For additional product information and ordering, please contact Ascent Research.
